Search results for "Intestin"

showing 10 items of 2215 documents

Mécanisme d’absorption intestinale des acides gras à longue chaîne : rôle émergent du CD36

2012

International audience; Excessive lipid intake, associated with a qualitative imbalance, favors the development of obesity and associated diseases. Among the organs involved in lipid homeostasis, the small intestine remains the most poorly known although it is responsible for the lipid bioavailability and largely contributes to the regulation of postprandial hypertriglyceridemia. The mechanism of long chain fatty acid (LCFA) intestinal absorption is not totally elucidated. The synthesis of recent literature indicates that the intestine is able to adapt its absorption capacity to the fat content of the diet. This adaptation takes place through a fat-coordinated induction of LBP and apolipopr…

lipid absorption[SDV]Life Sciences [q-bio]CD36Postprandial hypertriglyceridemiaMedicine (miscellaneous)lcsh:TP670-699intestinal adaptationHypertriglycéridémie postprandiale030204 cardiovascular system & hematologyBiochemistryIntestinal absorption03 medical and health sciences0302 clinical medicineLipid-binding proteinsChylomicronsmedicineCd36intestinesensing030304 developmental biologyIntestinal lipid absorption0303 health sciencesNutrition and DieteticsbiologyChemistryIntestinal lipid absorptionHypertriglyceridemiamedicine.diseaseMolecular biologySmall intestine3. Good healthBioavailabilitymedicine.anatomical_structurePostprandialBiochemistrybiology.proteinlipids (amino acids peptides and proteins)lcsh:Oils fats and waxesAbsorption intestinale des lipidesLong chain fatty acid[SDV.AEN]Life Sciences [q-bio]/Food and NutritionFood ScienceChylomicronOléagineux, Corps gras, Lipides
researchProduct

Lipodepsipeptides from Pseudomonas syringae are partially proteolyzed and are not absorbed by humans: An in vitro study

2008

There are some concerns about the use of Pseudomonas-based products as biocontrol agents because of the hemolytic activity shown by their metabolites. The effects of Pseudomonas lipodepsipeptides (LDPs) on mammals via ingestion and the LDP degradation during the digestion and intestinal permeability have not been evaluated. In this research, the susceptibility of different LDPs to degradation was assayed with enzymatic gastrointestinal digestion, and intestinal permeability to LDPs was investigated in an in vitro system based on an intestinal cell layer system. Results demonstrated that trypsin and chymotrypsin hydrolyze up to 50% of the various LDPs, and that proteolysis was further increa…

lipodepsipeptidesProteolysisPseudomonas syringaelipodepsipeptides; Pseudomonas syringae; enzymatic digestionPronaseIn Vitro TechniquesPeptides CyclicRisk AssessmentMicrobiologyMicrobiologyenzymatic digestionmedicinePseudomonas syringaeHumansLife SciencePest Control BiologicalIntestinal permeabilitybiologymedicine.diagnostic_testPseudomonasbiology.organism_classificationTrypsinmedicine.diseaseIntestinal AbsorptionBiochemistryConsumer Product SafetyDigestionDigestionFood Sciencemedicine.drugPseudomonadaceaeJournal of Food Protection
researchProduct

Exploring Bioequivalence of Dexketoprofen Trometamol Drug Products with the Gastrointestinal Simulator (GIS) and Precipitation Pathways Analyses

2019

The present work aimed to explain the differences in oral performance in fasted humans who were categorized into groups based on the three different drug product formulations of dexketoprofen trometamol (DKT) salt&mdash

liquid–liquid phase separationSALT DISPROPORTIONATIONgastrointestinal absorptionSodiumlcsh:RS1-441Pharmaceutical ScienceExcipientchemistry.chemical_elementSalt (chemistry)Hydrochloric acidSOLUBILITYCalciumBioequivalenceArticlelcsh:Pharmacy and materia medicachemistry.chemical_compoundFLUIDSEMAoral absorptionABSORPTIONmedicinePharmacology & PharmacySUPERSATURATED SOLUTIONSdexketoprofenSimulationchemistry.chemical_classificationScience & TechnologyChemistryliquid-liquid phase separationPhosphateDexketoprofenSIMILARITIESgastrointestinal simulatorin vitro dissolutionIN-VITRO DISSOLUTIONLife Sciences & BiomedicineVIVO DISSOLUTIONMETHODOLOGYmicroscopy imagingmedicine.drugPharmaceutics
researchProduct

Intestinal distribution and fecundity of two species ofDiplostomumparasites in definitive hosts

2005

This paper investigated the intestinal distribution and fecundity of 2 species ofDiplostomumparasites,D. spathaceumandD. pseudospathaceum, in 2 species of definitive hosts, herring gull (Larus argentatus) and common gull (L. canus), using both empirical field data and experimental infections. At the level of individual hosts, the parasite species occupied different parts within the intestine, but the fecundity of the worms, measured as the number of eggs in the uterus, did not differ between the parasite species except in wild common gulls. Interestingly, egg numbers in individual hosts were positively correlated between the parasite species suggesting that some birds provided better resour…

media_common.quotation_subjectZoologyTrematode InfectionsCompetition (biology)Host-Parasite InteractionsCharadriiformesbiology.animalPrevalenceAnimalsParasite hostingIntestinal Diseases ParasiticParasite Egg Countmedia_commonbiologyReproductive successBird DiseasesEcologyHost (biology)FishesFecunditybiology.organism_classificationIntestinesFertilityInfectious Diseasesembryonic structuresHerring gullAnimal Science and ZoologyParasitologyTrematodaTrematodaLarusParasitology
researchProduct

Data from: Phosphorus limitation enhances parasite impact: feedback effects at the population level

2014

Background: Nutrient deficiency affects the growth and population dynamics of consumers. Endoparasites can be seen as consumers that drain carbon (C) or energy from their host while simultaneously competing for limiting resources such as phosphorus (P). Depending on the relative demands of the host and the parasite for the limiting nutrient, intensified resource competition under nutrient limitation can either reduce the parasite?s effect on the host or further reduce the fitness of the nutrient-limited host. So far, knowledge of how nutrient limitation affects parasite performance at the host population level and how this affects the host populations is limited. Results: We followed the po…

medicine and health carenutrient limitationDaphnia magnafungiGlugoides intestinalisMedicineHost-parasite interactionLife sciences
researchProduct

Development of Gut-Associated Lymphoid Tissues

2015

The intestinal mucosa is one of our largest and most exposed body surfaces, thus creating a vital need for efficient immune responses. In order to coordinate those, the mucosal immune system comprises several organized lymphoid structures; the best-studied ones are mesenteric lymph nodes, Peyer’s patches, cryptopatches, and isolated lymphoid follicles. Their developmental requirements and time frames overlap to a certain extent, but are greatly divergent in many aspects. Furthermore, they can be influenced by a number of environmental impacts, such as food or the intestinal microbiota. In the following chapter we will try to shed some light on the processes that occur during the development…

medicine.anatomical_structureImmune systemIntestinal mucosaImmunologymedicinePeyer's patchMesenteric lymph nodesBiology
researchProduct

P087 Increased wnt ligands expression in M2c macrophages is associated with fibrosis in Stat6 knockout mice

2017

medicine.diagnostic_testbusiness.industryGastroenterologyWnt signaling pathwayGeneral Medicinemedicine.diseasePhenotypeFlow cytometryIntestinal mucosaFibrosisKnockout mousemedicineCancer researchSignal transductionbusinessSTAT6Journal of Crohn's and Colitis
researchProduct

Differential Effects of Antibiotic Therapy on the Structure and Function of Human Gut Microbiota

2013

The human intestinal microbiota performs many essential functions for the host. Antimicrobial agents, such as antibiotics (AB), are also known to disturb microbial community equilibrium, thereby having an impact on human physiology. While an increasing number of studies investigate the effects of AB usage on changes in human gut microbiota biodiversity, its functional effects are still poorly understood. We performed a follow-up study to explore the effect of ABs with different modes of action on human gut microbiota composition and function. Four individuals were treated with different antibiotics and samples were taken before, during and after the AB course for all of them. Changes in the…

medicine.drug_classAntibioticslcsh:MedicineGut floradigestive systemMicrobiologyAntibiotic resistanceRNA Ribosomal 16SDrug Resistance BacterialmedicineHumansMicrobiomeMode of actionlcsh:ScienceMultidisciplinarybiologyMicrobiotalcsh:RBiodiversitybiology.organism_classificationAntimicrobialResistomeAnti-Bacterial AgentsGastrointestinal TractMetagenomicsMetagenomelcsh:QResearch ArticleFollow-Up StudiesPLoS ONE
researchProduct

Combined oral prolonged-release oxycodone and naloxone in chronic pain management

2013

Introduction: The use of opioids is associated with unwanted adverse effects, particularly opioid-induced constipation (OIC). The adverse effects of opioids on gastrointestinal function are mediated by the interaction with opioid receptors in the gastrointestinal tract. The most common drugs used for relieving OIC are laxatives, which do not address the opioid receptor-mediated bowel dysfunction and do not provide sufficient relief. Areas covered: This paper discusses the role of a combination of prolongedrelease formulation of oxycodone (OX) and naloxone (N) in the prevention and management of OIC, reporting efficacy and safety outcome of controlled studies. In a therapeutic area of great …

medicine.drug_classSettore MED/41 - Anestesiologiacancer pain chronic pain opioid-antagonist opioids oxycodone--naloxone combinationNaloxonemedicineHumansPharmacology (medical)Adverse effectPharmacologybusiness.industryNaloxoneChronic painGeneral Medicinemedicine.diseaseAnalgesics OpioidDrug CombinationsTreatment OutcomeOpioidAnesthesiaDelayed-Action PreparationsChronic PainGastrointestinal functionbusinessCancer painOxycodoneOpioid antagonistOxycodonemedicine.drug
researchProduct

Optimizing the use of linaclotide in patients with constipation-predominant irritable bowel syndrome : an expert consensus report

2017

INTRODUCTION: Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by chronic or recurrent abdominal pain in association with defecation or a change in bowel habits. A predominant disorder of bowel habits, IBS is classified into three main subtypes: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D) and IBS alternating between constipation and diarrhea (IBS-M). Linaclotide is a first-in-class, oral, once-daily guanylate cyclase-C receptor agonist (GC-CA) that is licensed for the symptomatic treatment of moderate-to-severe IBS-C in adults. This review aims to facilitate and optimize clinical practices, establishing common guidelines to monitor patie…

medicine.medical_specialtyAbdominal painAbdominal painConstipationReviewRecommendationsGastroenterologyIrritable Bowel Syndrome03 medical and health scienceschemistry.chemical_compound0302 clinical medicineBloatingGastrointestinal AgentsInternal medicinemedicineHumansPharmacology (medical)030212 general & internal medicineLinaclotideGastroenterologiaIrritable bowel syndromeMedicine(all)business.industryBloatingGastroenterologyIntestins -- MalaltiesGeneral Medicinemedicine.diseaseSíndrome do Intestino IrritávelRheumatologyDiarrheaTreatment OutcomechemistryDefecationLinaclotide030211 gastroenterology & hepatologyPatient managementmedicine.symptomConstipation-predominant irritable bowel syndromebusinessPeptidesReceptors Atrial Natriuretic FactorConstipation
researchProduct